9
Participants
Start Date
October 3, 2017
Primary Completion Date
May 31, 2020
Study Completion Date
May 31, 2020
Hydroxychloroquine
Subjects will receive a pre-transplant 200 mg daily dose of HCQ 30 days before TPAIT and will continue on the drug for 3 months after surgery.
Placebo
Subjects will receive a pre-transplant placebo 30 days before TPAIT and will continue on the placebo for 3 months after surgery.
Cleveland Clinic, Cleveland
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
OTHER
Stanford University
OTHER
The Cleveland Clinic
OTHER